Clinical Trials Browser

Phase 1 × Prostatic Neoplasms × pasireotide × Clear all

NCT01646684 2020-12-21

Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Pasireotide LAR in Patients With Castration Resistant Prostate Cancer

Phase 1 Completed

Prostatic Neoplasms